About Us

Complete Genomics is a life sciences company that has developed and commercialized an innovative DNA sequencing platform that we believe will become the preferred solution for complete human genome sequencing and analysis.

Our Complete Genomics Analysis Platform, or CGA™ Platform, combines Complete Genomics' proprietary human genome sequencing technology with our advanced informatics and data management software.  We offer this solution as an innovative, end-to-end, outsourced service and provide customers with data that is immediately ready to be used for genome-based research.

Our solution, CGA™ Service, provides academic and biopharmaceutical researchers with complete human genomic data and analysis at an unprecedented quality, cost, and scale.

By broadly enabling researchers to conduct large-scale complete human genome studies, we believe that our solution has the potential to revolutionize medical research and expand understanding of the basis, treatment and prevention of complex diseases.

Technology

Our human genome sequencing technology, which is based on our proprietary DNA arrays and ligation-based read technology, is superior to existing commercially available complete human genome sequencing methods in terms of quality, cost and scale. Because we have optimized our technology platform and our operations for the unique requirements of high-throughput complete human genome sequencing, we are able to achieve accuracy levels of 99.999% at a total cost that is significantly less than the total cost of purchasing and using commercially available DNA sequencing instruments.

End-to-End Outsourced Service

While our competitors primarily sell DNA sequencing instruments and reagents that produce raw sequenced data, requiring their customers to invest significant additional resources to process that raw data into a form usable for research, we offer our customers an end-to-end, outsourced solution that delivers research-ready genomic data.

Research-Ready Data

Our genome sequencing center, which began commercial operations in May 2010, combines a high-throughput sample preparation facility, a collection of our proprietary high-throughput sequencing instruments and a large- scale data center. Our customers ship us their samples via common carrier services such as Federal Express and United Parcel Service. We then sequence and analyze these samples and provide our customers with finished, research-ready data, enabling them to focus exclusively on their single highest priority, discovery.